Comparing Heparin-Bonded Endoluminal Bypass to Surgical Bypass
Author Information
Author(s): Lensvelt Mare MA, Holewijn Suzanne, Fritschy Wilbert M, Wikkeling Otmar RM, van Walraven Laurens A, Wallis de Vries Bas M, Zeebregts Clark J, Reijnen Michel MPJ
Primary Institution: Rijnstate Hospital, Department of Surgery, Arnhem, The Netherlands
Hypothesis
The heparin-bonded endoluminal bypass provides equal patency rates compared to the venous bypass and is associated with improved quality of life.
Conclusion
The SuperB trial aims to show that the heparin-bonded endograft has similar patency rates to the surgical bypass while improving quality of life.
Supporting Evidence
- The heparin-bonded endograft may improve patency rates compared to traditional methods.
- Endovascular techniques are less invasive and may lead to quicker recovery.
- The study is designed to assess both patency rates and quality of life improvements.
Takeaway
This study is looking at whether a new type of less invasive surgery can work just as well as the traditional surgery for leg artery problems, but with fewer complications.
Methodology
A multicentre randomized controlled trial comparing heparin-bonded endoluminal bypass to surgical femoro-popliteal bypass.
Potential Biases
Surgeons must have prior experience with endoluminal bypasses to prevent learning curve bias.
Participant Demographics
Patients with peripheral arterial occlusive disease, Rutherford category 3-6.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website